Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer's disease.

Devanand DP, Liu X, Brown PJ, Huey ED, Stern Y, Pelton GH.

Int J Alzheimers Dis. 2012;2012:483469. doi: 10.1155/2012/483469. Epub 2012 Feb 1.

2.

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.

Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH.

Biol Psychiatry. 2008 Nov 15;64(10):871-9. doi: 10.1016/j.biopsych.2008.06.020. Epub 2008 Aug 23.

3.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
4.

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.

Apostolova LG, Hwang KS, Kohannim O, Avila D, Elashoff D, Jack CR Jr, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.

5.

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.

Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR Jr, Aisen PS, Thal LJ.

Neurology. 2008 Jan 15;70(3):191-9. doi: 10.1212/01.wnl.0000287091.57376.65.

PMID:
18195264
6.

Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment.

Gifford KA, Liu D, Damon SM, Chapman WG 4th, Romano Iii RR, Samuels LR, Lu Z, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;44(1):309-18. doi: 10.3233/JAD-140636.

7.

Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.

Varon D, Barker W, Loewenstein D, Greig M, Bohorquez A, Santos I, Shen Q, Harper M, Vallejo-Luces T, Duara R; Alzheimer's Disease Neuroimaging Initiative.

Int J Geriatr Psychiatry. 2015 Feb;30(2):192-200. doi: 10.1002/gps.4126. Epub 2014 May 12.

PMID:
24816477
8.

Fractionating verbal episodic memory in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Jan 15;54(2):1530-9. doi: 10.1016/j.neuroimage.2010.09.005. Epub 2010 Sep 9.

9.

Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.

Hall A, Muñoz-Ruiz M, Mattila J, Koikkalainen J, Tsolaki M, Mecocci P, Kloszewska I, Vellas B, Lovestone S, Visser PJ, Lötjonen J, Soininen H; Alzheimer Disease Neuroimaging Initiative; AddNeuroMed consortium; DESCRIPA and Kuopio L-MCI.

J Alzheimers Dis. 2015;44(1):79-92. doi: 10.3233/JAD-140942.

PMID:
25201784
10.

Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics.

Epstein NU, Saykin AJ, Risacher SL, Gao S, Farlow MR; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Drugs Aging. 2010 Aug 1;27(8):677-86. doi: 10.2165/11538260-000000000-00000.

11.

Predicting clinical scores from magnetic resonance scans in Alzheimer's disease.

Stonnington CM, Chu C, Klöppel S, Jack CR Jr, Ashburner J, Frackowiak RS; Alzheimer Disease Neuroimaging Initiative.

Neuroimage. 2010 Jul 15;51(4):1405-13. doi: 10.1016/j.neuroimage.2010.03.051. Epub 2010 Mar 25.

12.

Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.

Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Curr Alzheimer Res. 2009 Aug;6(4):347-61.

13.

Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S.

Cochrane Database Syst Rev. 2015 Mar 5;(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Review.

PMID:
25740785
14.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
15.

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Ann Neurol. 2009 Apr;65(4):403-13. doi: 10.1002/ana.21610.

16.

Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.

Apostolova LG, Morra JH, Green AE, Hwang KS, Avedissian C, Woo E, Cummings JL, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 May 15;51(1):488-99. doi: 10.1016/j.neuroimage.2009.12.125. Epub 2010 Jan 18.

17.

Early detection of Alzheimer's disease using MRI hippocampal texture.

Sørensen L, Igel C, Liv Hansen N, Osler M, Lauritzen M, Rostrup E, Nielsen M; Alzheimer's Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing.

Hum Brain Mapp. 2016 Mar;37(3):1148-61. doi: 10.1002/hbm.23091. Epub 2015 Dec 21.

PMID:
26686837
18.

The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.

Cavedo E, Redolfi A, Angeloni F, Babiloni C, Lizio R, Chiapparini L, Bruzzone MG, Aquino D, Sabatini U, Alesiani M, Cherubini A, Salvatore E, Soricelli A, Vernieri F, Scrascia F, Sinforiani E, Chiarati P, Bastianello S, Montella P, Corbo D, Tedeschi G, Marino S, Baglieri A, De Salvo S, Carducci F, Quattrocchi CC, Cobelli M, Frisoni GB.

J Alzheimers Dis. 2014;40(4):941-52. doi: 10.3233/JAD-132666.

PMID:
24577455
19.

Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.

Ye J, Farnum M, Yang E, Verbeeck R, Lobanov V, Raghavan N, Novak G, DiBernardo A, Narayan VA; Alzheimer’s Disease Neuroimaging Initiative.

BMC Neurol. 2012 Jun 25;12:46. doi: 10.1186/1471-2377-12-46.

20.

MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.

Devanand DP, Bansal R, Liu J, Hao X, Pradhaban G, Peterson BS.

Neuroimage. 2012 Apr 15;60(3):1622-9. doi: 10.1016/j.neuroimage.2012.01.075. Epub 2012 Jan 25.

Supplemental Content

Support Center